Pulmonary Hypertension:
Expert Interactive Learning App

The 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension provide updated, evidence-based recommendations to optimize care for patients with pulmonary vascular disease. Key advances include lowering the hemodynamic threshold for pulmonary hypertension to a mean pulmonary arterial pressure (mPAP) >20 mmHg, incorporating pulmonary vascular resistance (PVR) >2 Wood Units into the definition of pre-capillary pulmonary hypertension, introducing a simplified three-step diagnostic pathway (suspicion, detection, and confirmation), and emphasizing multi-parameter risk assessment (using 3-strata at baseline and 4-strata during follow-up) to guide risk-based, goal-oriented therapeutic strategies.